Table 6.

Independent risk factors associated with all-cause mortality among adult inpatients who received colistimethate sodium for ≥48 h as determined by multivariate logistic regression analysis.

Independent Risk Factor	All-Cause Mortality
	aOR (95% CI)	p-Value
Charlson comorbidity index (CCI) upon admission ≥5	4.514 (2.443–8.530)	<0.0001
Concomitant use of vasopressors during CMS therapy	7.76 (4.238–14.56)	<0.0001
CMS-induced AKI	4.117 (2.231–7.695)	<0.0001

Abbreviations: AKI = acute kidney injury, CMS = colistimethate sodium, aOR = adjusted odds ratio, CI = confidence interval.